Stockreport

How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart [Yahoo! Finance]

Dianthus Therapeutics, Inc.  (DNTH) 
PDF polyneuropathy (CIDP), after meeting interim responder goals ahead of schedule. At the same time, the FDA agreed to broaden clinical development changes for clasepruba [Read more]